Veterans Affairs committee  Again, thank you so much for this. I think this is very informative. I have two questions, but first, I would like to start with the statement that I'm very good with “very likely”, and I'm also very comfortable with what Health Canada put out. I think we must acknowledge that t

Veterans Affairs committee  We've had very powerful testimony today. A couple of things keep coming to me. One of them is a comment that one of you made about how just knowing about the exposure can be a relief to the person. Realizing that there are veterans in this country who don't know right now why t

Veterans Affairs committee  That is perfect for me because the next thing I want to ask is about informed consent. Right now about 5% of military personnel can get it if they ask for it or if they can't take something else. One of the concerns I have is, are they receiving the informed consent to take that?

Veterans Affairs committee  Thank you so much for being here. I really appreciate the testimony. I'm going to start with you, Dr. Nevin. One of the things that you talked about so clearly was the warning label, basically the monograph, which I think you referred to, that Health Canada now has on mefloquine

Veterans Affairs committee  Thank you. I think that's a really important part to consider. You also talked about some veterans not disclosing because their experience is that this feels like what we think PTSD is but they weren't in active combat and they didn't see those things, so they wonder why they ar

Veterans Affairs committee  It is complex and making sure people are getting the correct treatment is something that we should all be concerned about.

Veterans Affairs committee  That's right. Thank you so much.

Veterans Affairs committee  Thank you for speaking about the informed choice of taking mefloquine. We heard earlier about the 5%, or less than 5%. What is the process that they're being asked to follow and are they being given the proper information before they make the decision to take mefloquine? Is that

Veterans Affairs committee  Okay. For the awareness piece, how do we build awareness so that people know to ask that question?

Veterans Affairs committee  Thank you. I think that's really important. I have one last question, and I don't even know if it's a question as much as a statement, but I would like to hear your response. What I understand from all of this is that we don't even know how many veterans have taken mefloquine. W

Veterans Affairs committee  Okay. How do we even start? As was said earlier, it's this cohort—and over a period of time it has lessened—that we need to care for in a respectful way, but we don't even know who they are.

Veterans Affairs committee  Thank you so much.

Veterans Affairs committee  Thank you both for being here today. One of the things I've heard loud and clear through this process is that research is needed, and how much we don't know is the issue at hand. Could I ask both of you to tell us what research is specifically needed in Canada?

Veterans Affairs committee  You talked earlier, Dr. Douglas, about the screening process. I'm just wondering if you could talk to us about mefloquine. Is there a screening process? How do you know? You talked earlier about the fact that it's not necessarily in the records, and you also spoke about something

Veterans Affairs committee  You learned about this because one of your patients informed you—